Type 2 Diabetes Incidence Up With Higher Intake of Ultraprocessed Food
By Elana Gotkine HealthDay Reporter
FRIDAY, Sept. 27, 2024 -- A higher intake of ultraprocessed food (UPF) is associated with an increased incidence of type 2 diabetes mellitus, according to a study published online Sept. 16 in The Lancet Regional Health.
Samuel J. Dicken, from University College London, and colleagues conducted a prospective cohort analysis of the European Prospective Investigation into Cancer and Nutrition cohort to examine the association between degree of food processing and incident type 2 diabetes. Dietary intake was assessed at baseline and classified as unprocessed/minimally processed food (MPF), processed culinary ingredients (PCI), processed food (PF), and UPF.
The researchers identified 14,236 type 2 diabetes mellitus cases during an average 10.9 years of follow-up of 311,892 individuals. Incident type 2 diabetes was 17 percent higher in association with each 10 percent increment of total daily food intake from UPF. The incidence of type 2 diabetes mellitus was lower in association with each 10 percent increment in MPF + PCI (hazard ratio, 0.94) or PF intake (hazard ratio, 0.92). Lower incident type 2 diabetes mellitus was seen in association with replacing UPF with MPF + PCI or PF. Heterogeneity was seen across subgroups of UPF, with lower incident type 2 diabetes mellitus in association with breads, biscuits and breakfast cereals, sweets and desserts, and plant-based alternatives.
"Higher UPF intake was associated with higher incident type 2 diabetes mellitus, whereas higher intakes of foods with less processing were associated with lower incident type 2 diabetes mellitus," the authors write.
One author disclosed ties to Amazon; a second author disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Metformin Beneficial for Osteoarthritis Knee Pain in Overweight, Obesity
THURSDAY, May 1, 2025 -- For patients with overweight or obesity and symptomatic knee osteoarthritis, metformin is associated with a greater improvement in knee pain than placebo...
Many Medicaid Enrollees Have Restricted Access to SGLT2 Inhibitors, GLP-1 Receptor Agonists
WEDNESDAY, April 30, 2025 -- Many Medicaid enrollees with type 2 diabetes have restricted access to cardioprotective medications, including sodium-glucose cotransporter-2...
Sodium-Glucose Cotransporter 2 Inhibitors Increase Risk for Falls in Patients With Diabetes
WEDNESDAY, April 30, 2025 -- Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is an independent risk factor for falls in people with type 2 diabetes, according to a study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.